| Literature DB >> 34732887 |
Patricia González-Rodríguez1, Enrico Zampese1, Kristen A Stout1, Jaime N Guzman1, Ema Ilijic1, Ben Yang1, Tatiana Tkatch1, Mihaela A Stavarache2, David L Wokosin1, Lin Gao3, Michael G Kaplitt2, José López-Barneo3, Paul T Schumacker4, D James Surmeier5.
Abstract
Loss of functional mitochondrial complex I (MCI) in the dopaminergic neurons of the substantia nigra is a hallmark of Parkinson's disease1. Yet, whether this change contributes to Parkinson's disease pathogenesis is unclear2. Here we used intersectional genetics to disrupt the function of MCI in mouse dopaminergic neurons. Disruption of MCI induced a Warburg-like shift in metabolism that enabled neuronal survival, but triggered a progressive loss of the dopaminergic phenotype that was first evident in nigrostriatal axons. This axonal deficit was accompanied by motor learning and fine motor deficits, but not by clear levodopa-responsive parkinsonism-which emerged only after the later loss of dopamine release in the substantia nigra. Thus, MCI dysfunction alone is sufficient to cause progressive, human-like parkinsonism in which the loss of nigral dopamine release makes a critical contribution to motor dysfunction, contrary to the current Parkinson's disease paradigm3,4.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34732887 PMCID: PMC9189968 DOI: 10.1038/s41586-021-04059-0
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 69.504